Exagen Inc. (XGN)
NASDAQ: XGN · IEX Real-Time Price · USD
1.590
+0.030 (1.92%)
Mar 28, 2024, 4:30 PM EDT - Market closed

Exagen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Revenue
52.5545.5648.341.9840.3932.4426.81
Revenue Growth (YoY)
15.33%-5.66%15.07%3.93%24.50%21.01%-
Cost of Revenue
23.0924.2120.5916.5618.8115.3814.14
Gross Profit
29.4621.3527.7125.4221.5817.0612.67
Selling, General & Admin
47.4352.0244.5437.0328.719.6818.82
Research & Development
4.879.887.243.572.182.131.55
Other Operating Expenses
05.510000.140.19
Operating Expenses
52.2967.451.7840.630.8821.9420.56
Operating Income
-22.84-46.05-24.07-15.19-9.3-4.88-7.89
Interest Expense / Income
2.342.452.632.573.492.872.95
Other Expense / Income
-1.52-0.83-0.02-0.98-0.780.2115.35
Pretax Income
-23.66-47.67-26.68-16.77-12.01-7.95-26.18
Income Tax
0.03-0.280.18-0.080.030.06-0.55
Net Income
-23.69-47.39-26.85-16.69-12.04-8.01-25.63
Preferred Dividends
000018.2410.477.14
Net Income Common
-23.69-47.39-26.85-16.69-30.28-18.48-32.77
Shares Outstanding (Basic)
18171613400
Shares Outstanding (Diluted)
18171613400
Shares Change
3.50%6.95%26.44%252.99%5580.14%--
EPS (Basic)
-1.34-2.77-1.68-1.32-8.46-293.34-520.18
EPS (Diluted)
-1.34-2.77-1.68-1.32-8.46-293.34-520.18
Free Cash Flow
-15.27-36.46-22.64-14.54-9.81-9.5-11.48
Free Cash Flow Per Share
-0.86-2.13-1.42-1.15-2.74-150.78-182.18
Gross Margin
56.06%46.86%57.37%60.55%53.43%52.59%47.26%
Operating Margin
-43.46%-101.07%-49.83%-36.18%-23.02%-15.04%-29.42%
Profit Margin
-45.08%-104.00%-55.59%-39.75%-74.97%-56.97%-122.26%
Free Cash Flow Margin
-29.05%-80.03%-46.87%-34.64%-24.30%-29.28%-42.82%
EBITDA
-18.21-42.7-23.1-13.66-7.93-4.36-22.56
EBITDA Margin
-34.66%-93.71%-47.83%-32.53%-19.64%-13.42%-84.16%
Depreciation & Amortization
3.112.520.950.550.590.730.67
EBIT
-21.32-45.22-24.05-14.2-8.52-5.09-23.23
EBIT Margin
-40.57%-99.25%-49.80%-33.83%-21.10%-15.68%-86.66%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).